As for the gene sets specifically suppressed by the combined treatment, GSEA revealed cell cycle regulators (including CDC25C, and E2F1), p53‐related genes (such as CCNE1, CHEK1) and cancer‐related pathways (Fig. 5B and Table S4). This evidence concerns the gene E2F1 and cancer.